Amanda Baker - Adjunct Professor
- Pippa Starr
- Apr 23, 2024
- 2 min read
Updated: Apr 9
Amanda Baker is a clinical psychologist and National Health and Medical Research Council (NHMRC) Senior Research Fellow employed as a Professor in the School of Medicine and Public Health at the University of Newcastle. Her research has been supported by NHMRC fellowships continuously since 2003.
Amanda has over 250 publications. She focusses her research on the triad of mental, physical health and substance use disorders. Projects typically involve multi-site randomised controlled trials of psychological interventions among people with severe mental disorders or severe physical illness (e.g., cancer, cardiovascular disease) and tobacco, alcohol and other substance use problems. More>>
23 April 2024 - A Qualitive Study Using Nicotine Products
https://onlinelibrary.wiley.com/doi/10.1111/dar.13850
People in alcohol and other drugs (AOD) treatment have higher smoking prevalence than the wider population.
AOD service clients comfortably use combination nicotine replacement or vaping.
Both pharmacological interventions help manage nicotine cravings and withdrawal.
Quitline behavioural counselling is a highly valued support for smoking cessation.
Nicotine vaping can offer AOD service clients an acceptable cessation alternative.
18 July 2023
29 May 2023 - Letter To Mark Butler
January 2022 - Study: Barriers To Using Nicotine Vape Products
https://www.sciencedirect.com/science/article/abs/pii/S0306460321002823?via%3Dihub
People in AOD treatment stated VNPs satisfy nicotine cravings and behavioral habits.
VNPs should be easy to use, maintain and access to increase use to quit smoking.
Further research on VNPs to quit smoking among people in AOD treatment is required.
VNPs hold significant promise as smoking cessation aids among people in AOD treatment because of their unique ability to satisfy both nicotine cravings and behavioural habits. However, multiple barriers, such as accessibility, maintenance, and the challenges of reducing other substance use simultaneously also need to be addressed for optimal engagement in clinical trials with VNPs to quit smoking.
2 February 2022 - Response to the (TGA) scheduling delegates’ interim decision on nicotine.
